Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05325736

Improvement in Glycemic Response After Bariatric Surgery

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Weizmann Institute of Science · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

decipher the role of microbiota in glycemic response change after bariatric surgery

Detailed description

Despite the vast knowledge linking the gut microbiome to metabolism and the glucose response, the relation still remains unclear. hopefully, a deep understanding of the mechanisms underlying metabolic improvement following bariatric surgery will make it possible to identify targets for pharmacological intervention, which will reduce the need for surgery and its risks. Previous studies have characterized the microbiome after bariatric surgery, but most suffer from methodological limitations. The current study has the potential to be innovative and make a significant contribution to understanding the mechanisms involved in early metabolic improvement after bariatric surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREsleeve gastrectomy surgeryparticipants undergoing sleeve gastrectomy surgery
PROCEDUREgastric bypass surgeryparticipants undergoing gastric bypass surgery
PROCEDUREcontrolcholecystectomy
PROCEDUREPancreatectomyCollecting a sample of an unidentified healthy pancreas to extract insulin-secreting beta cells from the sample

Timeline

Start date
2021-07-01
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2022-04-13
Last updated
2025-03-26

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT05325736. Inclusion in this directory is not an endorsement.